The influence of xenon on regulation of the autonomic nervous system in patients at high risk of perioperative cardiac complications

British Journal of Anaesthesia

Volumn 96, Issue 4, 2006, Pages 427-436

  Hanss, R ^a   Bein, B ^a   Turowski, P ^a   Cavus, E ^a   Bauer, M ^a   Andretzke, M ^a   Steinfath, M ^a   Scholz, J ^a   Tonner, P H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Anaesthetics gases, xenon; Anaesthetics, i.v.; Heart rate, haemodynamic; Outcome; Surgical procedures, cardiovascular

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM; PROPOFOL; REMIFENTANIL; ROCURONIUM; XENON;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL SURGERY; ADRENERGIC TRANSMISSION; ADULT; AGED; ANESTHESIA INDUCTION; AORTA CLAMPING; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART DISEASE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HEART RATE VARIABILITY; HIGH RISK PATIENT; HOLTER MONITORING; HOSPITALIZATION; HUMAN; INHALATION ANESTHESIA; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; MALE; NEUROMODULATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT OUTCOME; WAKEFULNESS;

EID: 33645310162     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael028     Document Type: Article

References (38)

1. Blankensteijn JD. Mortality and morbidity rates after conventional abdominal aortic aneurysm repair. Semin Interv Cardiol 2000; 5: 7-13
2. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995; 82: 1026-60
3. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. A transoesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 1993; 48: 1045-9
4. Coburn M, Kunitz O, Baumert JH, et al. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth 2005; 94: 198-202
5. Hettrick DA, Pagel PS, Kersten JR, et al. Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 1998; 89: 1166-73
6. Goto T, Nakata Y, Morita S. Will xenon be a stranger or a friend?: The cost, benefit, and future of xenon anesthesia. Anesthesiology 2003; 98: 1-2
7. Dingley J, King R, Hughes L, et al. Exploration of xenon as a potential cardiostable sedative; a comparison with propofol after cardiac surgery. Anaesthesia 2001; 56: 829-35
8. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 93: 354-81
9. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-2
10. Ebert TJ, Kampine JP. Nitrous oxide augments sympathetic outflow: Direct evidence from human peroneal nerve recordings. Anesth Analg 1989; 4: 444-9
11. Kanaya N, Hirata N, Kurosawa S, Nakayama M, Namiki A. Differential effects of propofol and sevoflurane on heart rate variability. Anesthesiology 2003; 98: 34-40
12. Ishiguro Y, Goto T, Nakata Y, Terui K, Niimi Y, Morita S. Effect of xenon on autonomic cardiovascular control - comparison with isoflurane and nitrous oxide. J Clin Anesth 2000; 12: 196-201
13. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9
14. Hirsch JA, Bishop B. Respiratory sinus arrhythmia in humans: How breathing pattern modulates heart rate. Am J Physiol 1981; 241: H620-9
15. Fleisher LA. Heart rate variability as an assessment of cardiovascular status. J Cardiothorac Vasc Anesth 1996; 10: 659-71
16. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998; 98: 547-55
17. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-93
18. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrillation: Standards for acquisition and interpretation and assessment of interobserver variability. J Am Soc Echocardiogr 1996; 9; 556-66
19. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-41
20. Rautaharju PM, Calhoun HP, Chaitman BR. NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol 1992; 24(Suppl): 179-87
21. Nakata Y, Goto T, Morita S. Effects of xenon on hemodynamic responses to skin incision in humans. Anesthesiology 1999; 90: 406-10
22. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998; 98: 547-55
23. Hopf HB, Skyschally A, Heusch G, Peters J. Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology 1995; 82: 609-19
24. Kawase M, Komatsu T, Nishiwaki K, Kobayashi M, Kimura T, Shimada Y. Heart rate variability and arterial blood pressure variability show different characteristic changes during hemorrhage in isoflurane-anesthetized, mechanically ventilated dogs. Anesth Analg 2002; 94: 16-21
25. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev 1992; 72: 231-300
26. Luttropp HH, Thomasson R, Dahm S, Persson J, Werner O. Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol Scand 1994; 38: 121-5
27. Reinelt H, Marx T, Kotzerke J, et al. Hepatic function during xenon anesthesia in pigs. Acta Anaesthesiol Scand 2002; 46: 713-16
28. Utsumi J, Adachi T, Miyazaki Y, et al. The effect of xenon on spinal dorsal horn neurons: A comparison with nitrous oxide. Anesth Analg 1997; 84: 1372-6
29. Tramer MR, Moore RA, McQuay HJ. Propofol and bradycardia: Causation, frequency and severity. Br J Anaesth 1997; 78: 642-51
30. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20
31. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91: 1327-32
32. Homi HM, Yokoo N, Ma D, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99: 876-81
33. Weber NC, Toma O, Wolter JI, et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 2005; 144: 123-32
34. Stowe DF, Rehmert GC, Kwok WM, Weigt HU, Georgieff M, Bosnjak ZJ. Xenon does not alter cardiac function or major cation currents in isolated guinea pig hearts or myocytes. Anesthesiology 2000; 92: 516-22
35. Zhou W, Fontenot HJ, Liu S, Kennedy RH. Modulation of cardiac calcium channels by propofol. Anesthesiology 1997; 86: 670-5
36. Bein B, Renner J, Caliebe D, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005; 100: 610-6
37. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardio-protective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310
38. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004; 101: 9-20